Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aurinia Pharm Ord (NQ: AUPH )

12.86 USD +0.20 (+1.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,259,572
Open 12.70
Bid (Size) 12.88 (1)
Ask (Size) 12.91 (4)
Prev. Close 12.66
Today's Range 12.44 - 12.89
52wk Range 9.720 - 20.50
Shares Outstanding 128,156,427
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aurinia Announces Results of the 2021 Annual General Meeting
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) is pleased to announce that the eight incumbent directors of the Company were elected at the Company’s annual general... 
From Business Wire News Releases
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) today presented an analysis of its Phase 3 AURORA 1 study data at the European Renal Association – European Dialysis and... 
From Business Wire News Releases

Performance

YTD
-5.02%
-5.02%
1 Month
+17.34%
+17.34%
3 Month
-9.75%
-9.75%
6 Month
-14.38%
-14.38%
1 Year
-17.09%
-17.09%

More News

Read More
venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences
From Business Wire News Releases
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
From Business Wire News Releases
Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS™ (voclosporin) in Subjects with Lupus Nephritis
From Business Wire News Releases
How The Pieces Add Up: BIB Headed For $105
Tags ETFs
From ETF Channel
Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences
From Business Wire News Releases
Unusual Options Activity Insight: Aurinia Pharmaceuticals
Tags AUPH Benzinga BZI/UOA
From Benzinga
Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis
From Business Wire News Releases
Aurinia's Lupkynis Shows Sustained Renal Response Rates In Lupus Nephritis Patients
Tags AUPH News Biotech
From Benzinga
2 Grossly Undervalued Biotech Stocks That Could Double Your Money
Tags Market News IBB AGEN
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.